182 related articles for article (PubMed ID: 21180541)
1. The Effect of Metformin and Standard Therapy versus Standard Therapy alone in Nondiabetic Patients with Insulin Resistance and Nonalcoholic Steatohepatitis (NASH): A Pilot Trial.
Shields WW; Thompson KE; Grice GA; Harrison SA; Coyle WJ
Therap Adv Gastroenterol; 2009 May; 2(3):157-63. PubMed ID: 21180541
[TBL] [Abstract][Full Text] [Related]
2. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.
Huang MA; Greenson JK; Chao C; Anderson L; Peterman D; Jacobson J; Emick D; Lok AS; Conjeevaram HS
Am J Gastroenterol; 2005 May; 100(5):1072-81. PubMed ID: 15842581
[TBL] [Abstract][Full Text] [Related]
3. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
[TBL] [Abstract][Full Text] [Related]
4. Effect of a Probiotic and Metformin on Liver Aminotransferases in Non-alcoholic Steatohepatitis: A Double Blind Randomized Clinical Trial.
Shavakhi A; Minakari M; Firouzian H; Assali R; Hekmatdoost A; Ferns G
Int J Prev Med; 2013 May; 4(5):531-7. PubMed ID: 23930163
[TBL] [Abstract][Full Text] [Related]
5. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.
Harrison SA; Fecht W; Brunt EM; Neuschwander-Tetri BA
Hepatology; 2009 Jan; 49(1):80-6. PubMed ID: 19053049
[TBL] [Abstract][Full Text] [Related]
6. A Randomized Controlled Trial Comparing Efficacy of Pentoxifylline and Pioglitazone on Metabolic Factors and Liver Histology in Patients with Non-alcoholic Steatohepatitis.
Sharma BC; Kumar A; Garg V; Reddy RS; Sakhuja P; Sarin SK
J Clin Exp Hepatol; 2012 Dec; 2(4):333-7. PubMed ID: 25755455
[TBL] [Abstract][Full Text] [Related]
7. Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.
Abd El-Kader SM; Al-Shreef FM; Al-Jiffri OH
Afr Health Sci; 2016 Mar; 16(1):242-9. PubMed ID: 27358638
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trial.
Torres DM; Jones FJ; Shaw JC; Williams CD; Ward JA; Harrison SA
Hepatology; 2011 Nov; 54(5):1631-9. PubMed ID: 21748770
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial.
van der Aa MP; Elst MA; van de Garde EM; van Mil EG; Knibbe CA; van der Vorst MM
Nutr Diabetes; 2016 Aug; 6(8):e228. PubMed ID: 27571249
[TBL] [Abstract][Full Text] [Related]
10. Assessment of insulin resistance and effect of metformin in nonalcoholic steatohepatitis--a preliminary report.
Duseja A; Murlidharan R; Bhansali A; Sharma S; Das A; Das R; Chawla Y
Indian J Gastroenterol; 2004; 23(1):12-5. PubMed ID: 15106708
[TBL] [Abstract][Full Text] [Related]
11. Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.
Liew PL; Lee WJ; Wang W; Lee YC; Chen WY; Fang CL; Huang MT
Obes Surg; 2008 Jul; 18(7):847-53. PubMed ID: 18459024
[TBL] [Abstract][Full Text] [Related]
12. Haptoglobin Genotype and Vitamin E Versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis in China: A Multicenter, Randomized, Placebo-Controlled Trial Design.
Zang S; Chen J; Song Y; Bai L; Chen J; Chi X; He F; Sheng H; Wang J; Xie S; Xie W; Yang Y; Zhang J; Zheng M; Zou Z; Wang B; Shi J;
Adv Ther; 2018 Feb; 35(2):218-231. PubMed ID: 29411270
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G
Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582
[TBL] [Abstract][Full Text] [Related]
14. Correlation between insulin resistance and liver histology in patients with nonalcoholic steatohepatitis with and without obesity.
Lazar MV; Eapen M; Nair HR; Siyad I; Gopalakrishna R
Indian J Gastroenterol; 2020 Feb; 39(1):42-49. PubMed ID: 32222944
[TBL] [Abstract][Full Text] [Related]
15. Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.
Loomba R; Lutchman G; Kleiner DE; Ricks M; Feld JJ; Borg BB; Modi A; Nagabhyru P; Sumner AE; Liang TJ; Hoofnagle JH
Aliment Pharmacol Ther; 2009 Jan; 29(2):172-82. PubMed ID: 18945255
[TBL] [Abstract][Full Text] [Related]
16. Metformin in nonalcoholic steatohepatitis: a randomized controlled trial.
Kazemi R; Aduli M; Sotoudeh M; Malekzadeh R; Seddighi N; Sepanlou SG; Merat S
Middle East J Dig Dis; 2012 Jan; 4(1):16-22. PubMed ID: 24829630
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology.
Jung KY; Cho SY; Kim HJ; Kim SB; Song IH
J Clin Gastroenterol; 2014; 48(10):883-8. PubMed ID: 24440936
[TBL] [Abstract][Full Text] [Related]
18. Pentoxifylline with metformin treatment improves biochemical parameters in patients with nonalcoholic steatohepatitis.
Ćulafić M; Vezmar-Kovačević S; Dopsaj V; Oluić B; Bidžić N; Miljković B; Ćulafić Đ
J Med Biochem; 2020 Sep; 39(3):290-298. PubMed ID: 33269017
[TBL] [Abstract][Full Text] [Related]
19. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.
Gastaldelli A; Harrison SA; Belfort-Aguilar R; Hardies LJ; Balas B; Schenker S; Cusi K
Hepatology; 2009 Oct; 50(4):1087-93. PubMed ID: 19670459
[TBL] [Abstract][Full Text] [Related]
20. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
